Koyfin Home > Directory > Health Care > Boston Scientific Corp > EBITDA / Interest Expenses

Boston Scientific Corp EBITDA / Interest Expenses Chart (BSX)

Boston Scientific Corp annual/quarterly EBITDA / Interest Expenses from 2010 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Boston Scientific Corp EBITDA / Interest Expenses for the quarter ending September 09, 2020 was $7m a 32.92% increase of 2m year over year
  • Boston Scientific Corp EBITDA / Interest Expenses for the last 12 months ending September 09, 2020 was $5m a -23.33% decrease of -1m year over year
  • Boston Scientific Corp Annual EBITDA / Interest Expenses for 2019 was $6m a -77.36% decrease of -5m from 2018
  • Boston Scientific Corp Annual EBITDA / Interest Expenses for 2018 was $11m a 1.79% increase of 0m from 2017
  • Boston Scientific Corp Annual EBITDA / Interest Expenses for 2017 was $11m a 11.25% increase of 1m from 2016
Other Ratios Metrics:
  • Boston Scientific Corp Total Debt / Capital for the quarter ending December 12, 2018 was $44m a -1.42% decrease of -1m year over year
  • Boston Scientific Corp Other Liabilities for the quarter ending September 09, 2018 was $2,202m a -16.30% decrease of -359m year over year
  • Boston Scientific Corp Total Debt / Equity for the quarter ending December 12, 2018 was $80m a -2.59% decrease of -2m year over year
View Chart On Koyfin

Quarterly BSX EBITDA / Interest Expenses Data

09/2020$7m
06/2020$3m
03/2020$6m
12/2019$5m
09/2019$7m
06/2019$8m
03/2019$6m
12/2018$11m
09/2018$11m
06/2018$11m

Annual BSX EBITDA / Interest Expenses Data

2019$6m
2018$11m
2017$11m
2016$9m
2015$7m
2014$8m
2013$5m
2012$6m
2011$6m
2010$5m